Krishnansu S Tewari

Improved survival with bevacizumab in advanced cervical cancer.

Michael W Sill, Helen Huang, B. Monk, 2014, The New England journal of medicine.

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.

B. Monk, R. Burger, J. Kuo, 2009, Gynecologic oncology.

A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer.

Jiaru Bai, B. Monk, J. Chan, 2015, Gynecologic oncology.

Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition.

K. Tewari, Krishnansu S Tewari, Lindsey E Minion, 2018, Gynecologic oncology.